The most enriched gene set identified by the EMDomics analysis is a set of genes down-regulated in cancer cell lines with mutated TP53 (q-value = 9.33e − 14), suggesting the value of EMDomics for prioritizing pathways highly relevant to drug response in ovarian cancer. This evidence concerns the gene TP53 and ovarian carcinoma.